Menu Search
Equities

Hamilton Lane Inc

1M0:DUS

Hamilton Lane Inc

Actions
  • Price (EUR)187.00
  • Today's Change-1.00 / -0.53%
  • Shares traded50.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hamilton Lane Incorporated is a private markets investment company providing solutions to institutional and private wealth investors around the world. The Company offers a variety of investment solutions to address its clients' needs across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats covering some or all phases of private markets investment programs, which include customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data and analytics.

  • Revenue in USD (TTM)648.66m
  • Net income in USD181.81m
  • Incorporated2007
  • Employees700.00
  • Location
    Hamilton Lane Inc110 WASHINGTON STREET, SUITE 1300CONSHOHOCKEN 19428United StatesUSA
  • Phone+1 (610) 934-2222
  • Fax+1 (610) 617-9853
  • Websitehttps://www.hamiltonlane.com/en-us
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		HLNE:NSQ since
announced		Transaction
value
Cosette Pharmaceuticals IncDeal completed17 Jul 202417 Jul 2024Deal completed39.97%--
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.